Personalis, Inc. (PSNL)
14.98
+0.18
(+1.22%)
USD |
NASDAQ |
Nov 18, 16:00
14.99
+0.01
(+0.07%)
After-Hours: 20:00
Personalis Debt to Equity Ratio : 0.1749 for Sept. 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2026 | 0.1749 |
| June 30, 2026 | 0.1616 |
| March 31, 2026 | 0.1522 |
| December 31, 2025 | 0.1562 |
| September 30, 2025 | 0.2443 |
| June 30, 2025 | 0.2267 |
| March 31, 2025 | 0.2181 |
| December 31, 2024 | 0.2185 |
| September 30, 2024 | 0.2708 |
| June 30, 2024 | 0.4156 |
| March 31, 2024 | 0.3962 |
| December 31, 2023 | 0.3783 |
| September 30, 2023 | 0.3127 |
| June 30, 2023 | 0.2771 |
| March 31, 2023 | 0.2555 |
| December 31, 2022 | 0.2248 |
| Date | Value |
|---|---|
| September 30, 2022 | 0.2014 |
| June 30, 2022 | 0.22 |
| March 31, 2022 | 0.2095 |
| December 31, 2021 | 0.1934 |
| September 30, 2021 | 0.184 |
| June 30, 2021 | 0.0481 |
| March 31, 2021 | 0.0305 |
| December 31, 2020 | 0.0564 |
| September 30, 2020 | 0.055 |
| June 30, 2020 | 0.1218 |
| March 31, 2020 | 0.0168 |
| December 31, 2019 | 0.0187 |
| September 30, 2019 | 0.0209 |
| June 30, 2019 | 0.1755 |
| March 31, 2019 | -1.016 |
| December 31, 2018 | -0.3344 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Tempus AI, Inc. | 2.862 |
| 10X Genomics, Inc. | 0.0904 |
| Alamar Biosciences, Inc. (California) | 0.1394 |
| Champions Oncology, Inc. | 2.818 |
| Medpace Holdings, Inc. | 0.2931 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 291.60M |
| Total Liabilities (Quarterly) | 78.93M |
| Shareholders Equity (Quarterly) | 212.67M |
| Current Ratio | 4.508 |
| Net Debt Paydown Yield | 0.07% |